HERA - General Approach
An A.I.S.E and CEFIC initiative on
focused risk assessment for ingredients of
household cleaning products
David Scharer
Vice-Chair: HERA Members Forum and Management Team
HERA European Stakeholders Workshop: Brussels, Oct 2001
1
Presentation Outline
Objectives
General principles including scope
Communication
Organisation
Selection of substances
Risk assessment process
Consistency with EU White Paper
Acknowledgements and next steps today
HERA European Stakeholders Workshop: Brussels, Oct 2001
2
HERA - Organisation
Phase 1A
1999-2001
 Get organised
 Methodology
Phase 1B
2001-2002
 Extend to 10-15
substances
 3 substances
 Refine methods
& organisation
 Introductory
communications
 Proactive
communications
Phase 2
2002+
 Extend to wider
range of
substances used
in household
cleaning
products
HERA European Stakeholders Workshop: Brussels, Oct 2001
3
HERA - Organisation
CEFIC
HERA Sponsors
AISE
USA, Japan
Associations
HERA Steering Committee
Members Forum /
Companies
HERA
Management Team
Communications
Committee
Expert Task Forces
- Human Health
- Environmental
Supplier led
Substance Teams
Formulator Team
 Methodology
 Data gathering
 Data gathering
Expert advice
 Draft risk assessment
HERA European Stakeholders Workshop: Brussels, Oct 2001
4
HERA – Selection criteria
Phase 1A substances
 Variety – Physical properties, hazards
 Variety – Detergent & cleaning product functions
 Adequate data set available
 Volunteers available
 Fabric whitening agent - FWA-5
 Inorganic builder - Zeolite A
 Surfactant - Alkyl sulphate
HERA European Stakeholders Workshop: Brussels, Oct 2001
5
HERA - Phase 1A
Substance Comparison
EU Volume
Number of
Suppliers
Grades
(CAS #)
Coordination
with other
programmes
<1
1
1
EU HPV
~ 500
8 – 10
2
EU HPV
ICCA
40
US HPV
ICCA…
‘000
tonnes/yr
FWA -5
Zeolite A
(Zeodet)
Alkyl
Sulphate
family (C12-18)
~ 100
10+
(Cesio)
HERA European Stakeholders Workshop: Brussels, Oct 2001
6
HERA – Selection Criteria
Phase 1B Substances
 LEARN
 Broaden range of substances, functionalities
 Extend methodology
 Test family approach
 RESPOND
 Include EU Priority List substances
 Include Companies & Sectors wishing to volunteer
HERA European Stakeholders Workshop: Brussels, Oct 2001
7
HERA – Phase 1B Substances













Boric acid *
Fatty acid salts
Fatty alkyl ether sulphates
Linear alkylbenzene sulphonates (LAS)
Tetra-acetyl ethylene diamine (TAED)
Phosphonates
Polycyclic musk AHTN *
Polycyclic musk HHCB *
Polydimethylsiloxanes
Sodium carbonate
Sodium perborate (mono and tetrahydrate) *
Sodium percarbonate
Sodium tri-polyphosphate (STPP)
* EU priority list substances
HERA European Stakeholders Workshop: Brussels, Oct 2001
8
HERA – Risk Assessment Process
Organise
Gather
data
Assess
Review,
Publish
Comment,
Revise
Substance
Team
Suppliers,
Formulator
Sector Group,
Formulator team
HuH & Env
Expert teams
Expert &
Mgmt teams
HERA European Stakeholders Workshop: Brussels, Oct 2001
External panel,
stakeholders
9
HERA - Task Force Presentations
Human Health TF
Chair: Dr Christeine Lally
Environmental TF
Chair: Dr Kay Fox
Progress, and Lessons Learned
HERA European Stakeholders Workshop: Brussels, Oct 2001
10